Several studies investigated the potential of amino acid PET tracers for the diagnosis of molecular markers of gliomas, including the IDH genotype, 1p/19q codeletion and O-methyl guanine methyltransferase (MGMT) promoter methylation status [32,33,34,35]. Here, MGMT is linked to central nervous system cancer.